Related Experiment Video
Updated: Jun 5, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Treatments for RYR1-related disorders.
Sharika Raga1, Nicol Voermans2, Ivan Perez-Neri3
1Department of Paediatric Neurology, University of Cape Town, Cape Town, South Africa.
This review examines interventions for RYR1-related disorders, aiming to improve muscle and breathing function. It compares treatments like drugs and exercise against placebo or standard care to assess benefits and harms.
Area of Science:
- Neurology
- Genetics
- Pharmacology
- Rehabilitation
Background:
- RyR1-related disorders encompass permanent myopathies and episodic presentations like exertional myalgia and rhabdomyolysis.
- These conditions significantly impact motor and respiratory function, necessitating effective treatment strategies.
- Current treatment options and their comparative efficacy require systematic evaluation.
Purpose of the Study:
- To analyze the benefits and harms of pharmacological and non-pharmacological interventions for RYR1-related disorders.
- To compare interventions against placebo or standard care to improve motor and respiratory function.
- To reduce the frequency of episodic presentations in RYR1-related diseases.
Main Methods:
- This protocol outlines a Cochrane Review of interventions for RYR1-related disorders.
- Systematic review methodology will be employed to synthesize evidence.
- Outcomes will include changes in motor and respiratory function, episode frequency, and disease expression.
Main Results:
- This section is to be populated upon completion of the review.
- Results will detail the comparative effectiveness and safety of interventions.
- Analysis will focus on RYR1-related myopathies and episodic presentations.
Conclusions:
- This review will provide evidence-based recommendations for managing RYR1-related disorders.
- It aims to identify standardized outcome measures for future research.
- Findings will guide clinical practice and therapeutic development for these rare genetic muscle diseases.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
12:43Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Related Concept Videos
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Lysosomal Hydrolases
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...